BGLC Earnings

Quarterly EPS
$-0.75
Q3 2024
$-0.01
Q4 2024
$-0.35
Q1 2025
$-0.34
Q2 2025
$-0.40
Q3 2025
$-0.51
Q4 2025
$-0.23
Q1 2026
$-0.12
Q2 2026
Latest Revenue76.2K
Latest Net Income-286451
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1276.2K-286451-96.6%+64.7%
Q1 2026-$0.2322.8K-543575-98.9%+34.3%
Q4 2025-$0.51483.8K-1036117-80.8%-5,000.0%
Q3 2025-$0.402.5M-708991-3.3%+46.7%
Q2 2025-$0.342.3M-616172+14.5%-409.1%
Q1 2025-$0.352.1M-623327-10.3%-3,400.0%
Q4 2024-$0.012.5M-348319+11.0%-150.0%
Q3 2024-$0.752.6M-1345370+3.0%+52.2%
Q2 2024$0.112.0M199.1K
Q1 2024-$0.012.4M-103757
Q4 2023$0.022.3M308.5K
Q3 2023-$1.572.6M-2609189
BioNexus Gene Lab (BGLC) — Earnings